On Thursday night, scientists and other public health workers supported by the U.S. Centers for Disease Control and Prevention received an email from the agency
WASHINGTON — Days after retiring from the National Institutes of Health, the agency’s former director warned that two signature programs — an initiative to decipher
Dive Brief: The Federal Trade Commission has challenged a private equity firm’s attempt to buy Surmodics for approximately $627 million, the regulator said Thursday. Surmodics
Marty Makary, President Donald Trump’s nominee to run the Food and Drug Administration, said he would undertake an “assessment” of agency staffing if confirmed but
Kisunla and Leqembi are designed to target amyloid plaques in the brain in Alzheimer’s patients. Credit: Halfpoint Images via Getty Images. The UK’s National Institute
J&J is now looking to trial the therapy in other indications but has not specified details. Image credit: Shutterstock / josefkubes. Johnson & Johnson (J&J)
Announcing a new article publication for Cardiovascular Innovations and Applications journal. Patients with chronic kidney disease (CKD) often encounter cardiovascular complications, most commonly coronary heart
Multidrug-resistant bacteria pose a major threat to human health. Manipulation of bacterial genes at the transcriptional level is a potential strategy to fight antibiotic-resistant bacterial
The Furoscix 80 mg/10 ml subcutaneous injection is intended for oedema in adult CKD patients including those with nephrotic syndrome. Credit: Orawan Pattarawimonchai/Shutterstock. The US
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hi there. Today, we